E6 and E7 fusion immunoglobulin from human papilloma virus 16 induces dendritic cell maturation and antigen specific activation of T helper 1 response

Presentation of tumour antigens by dendritic cells and challenges faced

(2010) Neil C Robson et al.   CURRENT OPINION IN IMMUNOLOGY

Human Papillomavirus Vaccination in the Prevention of Cervical Neoplasia

(2010) Katharine Astbury et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Soluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reaction

(2009) Seon-Soo Kim et al.   BIOTECHNOLOGY LETTERS

Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection

(2009) Balasubramanyam Karanam et al.   IMMUNOLOGY AND CELL BIOLOGY

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells

(2008) Xuelian Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Innate immunity to virus infection

(2008) Osamu Takeuchi et al.   IMMUNOLOGICAL REVIEWS

Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques

(2008) Jian Yan et al.   VACCINE

Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen

(2008) Jian Yan et al.   VACCINE